RSV prevention for babies
The new antibody shot is the biggest change to baby lung season in a generation. Here is how it fits with the rest of what actually works.
The new antibody shot is the biggest change to baby lung season in a generation. Here is how it fits with the rest of what actually works.
By age 2, almost every child has had RSV at least once. For most healthy older kids and adults it is a bad cold. For babies under 6 months, particularly under 3 months, and for preemies of any age, it can move into the small airways of the lungs and cause bronchiolitis, dehydration, and respiratory failure fast enough to need hospital care.
The CDC puts the annual hospitalization number at 58,000 to 80,000 US infants. That is enormous. What changed in 2023 and held through 2026 is that we now have effective tools to cut that number by more than two thirds. Almost no parent uses all of them.
Nirsevimab (brand name Beyfortus) is a long-acting monoclonal antibody given as a single injection. It is not a vaccine. It hands your baby pre-made antibodies that hang around for about 5 months, which conveniently covers the RSV season.
The CDC currently recommends it for every infant under 8 months entering their first RSV season (mostly October through March in the US), and for high-risk infants between 8 and 19 months entering their second season. The clinical-trial efficacy against hospitalization is about 80 percent. Real-world data from the 2023 to 2024 season showed similar performance.
Side effects are mild. Mostly soreness at the injection site and occasional rash. It is funded through the Vaccines for Children program for eligible kids and is covered without copay by most commercial insurance.
Pfizer's Abrysvo is given to pregnant people between 32 and 36 weeks gestation between September and January. Antibodies cross the placenta and protect the newborn through the first 6 months.
You generally pick one path or the other. If you got the maternal vaccine at the right window, your newborn usually does not also get nirsevimab. If you did not, your baby gets nirsevimab after birth. Talk to your OB and pediatrician about timing. Both work. The choice often comes down to scheduling.
RSV spreads by droplets and by hands that touched a surface with droplets. The virus can survive on hard surfaces for several hours. The fix is unglamorous:
If you have a choice about when your baby enters daycare, fall and early winter are the hardest months. A baby starting daycare at 6 weeks in October will catch nearly every virus in rotation. The same baby starting daycare at 6 months in April will catch fewer, and with more mature lungs.
If you cannot delay, that is fine. Just stack the other tools. Get the antibody shot. Limit non-essential indoor visits. Keep grandparents away if they have any symptoms.
If RSV symptoms come with a fever, the age-of-baby rules change fast. Get an instant verdict on whether to call.
Try the fever checkerBreast milk passes maternal antibodies and slightly reduces the severity of respiratory infections in the first year. It is not a force field. Babies who breastfeed still get RSV. But formula-fed babies have a modestly higher rate of severe RSV outcomes in observational studies. If you are mixed feeding or considering, this is one more small reason to keep some breast milk in the picture if it works for your family. If it does not, the other tools still work.
Most babies start with what looks like a regular cold for a day or two: runny nose, cough, mild fever. Around day 3 to 5, RSV can sink into the lower airways. The signs to watch for:
Get the maternal vaccine or the baby's antibody shot, whichever the timing supports. Wash hands. Tell sick relatives the visit can wait two weeks. Watch your baby's breathing, not just the thermometer. Call your pediatrician at the first sign of trouble. That is the entire plan.